Join us! - MTBC Events and Field Trips

Search
Close this search box.

WNS: Can a Cure Be Effective?

Amid media announcements that the fungus that causes white-nose syndrome in bats has spread to California, and growing public concern, The Wildlife Society announced the most recent attempt to find a cure. On July 9, an article titled “Bacteria treatment helps bats survive white-nose syndrome,” suggested progress toward a cure. However, there is no evidence that human intervention can slow the spread or cure the disease. As I’ve reported, the best available studies from the Northeast indicate that population recovery at key sites is exceeding expectations, and that a cure is unnecessary, impractical to implement, and risks unintended negative consequences. 

Several treatments appear to be effective in countering the infection in captive bats. However, when released the bats remain susceptible to reinfection and death. By releasing such bats near the end of the cycle, when only those with greatest genetic resistance remain, we would risk diluting the remaining gene pool, reducing the odds of survival, just the opposite of the intended goal.

Given the odds of unintended consequences, it may be fortunate that effective implementation of a cure in wild bat populations is so logistically hopeless as to be virtually inconceivable. We must not put funding opportunities ahead of bat needs. Finally, during this time of extreme stress, it is urgent that we recognize the importance of avoiding hibernation disturbance regardless of good intentions. I urge a reallocation of resources from cure-hunting to habitat restoration and protection, beginning with the most important hibernation sites.

I have shared my response with the The Wildlife Society and encourage others to politely do the same.

Indiana myotis (Myotis sodalis) hibernating in a Kentucky cave. Through loss of key hibernation caves, this species had become endangered prior to the arrival of WNS. Restoration and protection of hibernation sites is the single most important step that can be taken to aid in the recovery of this and other cave-dwelling species.

Love our content? Support us by sharing it!

Facebook
Twitter
Email

Related Posts

Don't miss a post!

Get all the latest news from MTBC delivered straight to your inbox.

Michael Lazari Karapetian

Michael Lazari Karapetian has over twenty years of investment management experience. He has a degree in business management, is a certified NBA agent, and gained early experience as a money manager for the Bank of America where he established model portfolios for high-net-worth clients. In 2003 he founded Lazari Capital Management, Inc. and Lazari Asset Management, Inc.  He is President and CIO of both and manages over a half a billion in assets. In his personal time he champions philanthropic causes. He serves on the board of Moravian College and has a strong affinity for wildlife, both funding and volunteering on behalf of endangered species.